BIIB

$216.78 -0.45% $-0.98
Aug 21, 2026 04:00 AM

Biogen specializes in the development of therapies for neurological diseases, including multiple sclerosis and Alzheimer’s.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Aug 23, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Empower Your BIIB Trading Now

Maximize your trading efficiency with ohlcx.com. Our advanced trading system provides detailed insights and actionable strategies for BIIB. Don’t wait—Enhance your market performance today and see how our platform can help you achieve your trading goals!

Explore Insights Now

Frequently Asked Questions

Biogen adheres to strict regulatory standards set by health authorities, conducting regular audits and reviews of its processes.

Recent developments include new clinical trial results and potential product launches; for the latest updates, check their press releases.

Biogen faces challenges such as competition from other pharmaceutical companies and regulatory hurdles in drug approval processes.

You can invest in Biogen by purchasing shares through a brokerage account or investing in funds that include Biogen in their portfolio.

Positive clinical trial results can lead to stock price increases and greater market confidence in Biogen’s products.

Biogen employs a rigorous approach, utilizing clinical trials and research to ensure safety and efficacy before launching new treatments.

Key products include Tecfidera, Avonex, and Spinraza, which are used for various neurological conditions.

The outlook for Biogen’s stock can fluctuate based on market conditions, product performance, and overall economic factors.

Biogen is committed to sustainability initiatives aimed at reducing its environmental impact and improving community health.

Innovation is central to Biogen’s strategy, focusing on developing new therapies to address unmet medical needs in neurology.

Reveal Your BIIB Trading Now

Maximize your trading efficiency with OHLCX Markets. Our advanced trading system provides detailed insights and actionable strategies for BIIB. Don’t wait—Enhance your market performance today and see how our platform can help you achieve your trading goals!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.